Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
inTEST
INTT
$143M
| $1.41M | ﹤0.01% |
362,600
+24,000
| +7% | +$94.5K |
|
|
WMAR
1902
DELISTED
West Marine Inc
WMAR
| $1.41M | ﹤0.01% |
137,400
-36,500
| -21% | -$388K |
|
1903
Crown Crafts
CRWS
$31.6M
| $1.41M | ﹤0.01% |
180,750
+20,263
| +13% | +$169K |
|
|
HDNG
1904
DELISTED
Hardinge Inc
HDNG
| $1.41M | ﹤0.01% |
111,112
+78,882
| +245% | +$1.01M |
|
1905
Eagle Materials
EXP
$6.49B
| $1.41M | ﹤0.01% |
14,900
+10,629
| +249% | +$929K |
|
|
UBA
1906
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.41M | ﹤0.01% |
67,300
-6,500
| -9% | -$134K |
|
|
CYRN
1907
DELISTED
CYREN Ltd.
CYRN
| $1.4M | ﹤0.01% |
24,347
-1,110
| -4% | -$69.5K |
|
1908
Timberland Bancorp
TSBK
$352M
| $1.4M | ﹤0.01% |
132,900
+3,400
| +3% | +$36.4K |
|
|
ACOR
1909
DELISTED
Acorda Therapeutics
ACOR
| $1.4M | ﹤0.01% |
346
-1,467
| -81% | -$5.98M |
|
|
EMES
1910
DELISTED
Emerge Energy Services LP
EMES
| $1.4M | ﹤0.01% |
13,202
-166,788
| -93% | -$14.5M |
|
|
SALM
1911
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $1.39M | ﹤0.01% |
147,300
-9,300
| -6% | -$82.9K |
|
|
LITB
1912
LightInTheBox
LITB
$50.6M
| $1.39M | ﹤0.01% |
+36,433
| New | +$1.2M |
|
|
ECYT
1913
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.39M | ﹤0.01% |
+210,200
| New | +$2.37M |
|
|
FPP
1914
DELISTED
FieldPoint Petroleum Corporation
FPP
| $1.38M | ﹤0.01% |
250,800
+25,800
| +11% | +$137K |
|
1915
Rexford Industrial Realty
REXR
$8.63B
| $1.38M | ﹤0.01% |
97,089
+53,567
| +123% | +$762K |
|
|
OMED
1916
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.38M | ﹤0.01% |
+59,200
| New | +$1.46M |
|
1917
Cass Information Systems
CASS
$716M
| $1.38M | ﹤0.01% |
36,712
+21,308
| +138% | +$817K |
|
1918
Republic Bancorp
RBCAA
$1.96B
| $1.38M | ﹤0.01% |
58,000
+10,270
| +22% | +$240K |
|
1919
Orrstown Financial Services
ORRF
$850M
| $1.36M | ﹤0.01% |
82,500
+1,300
| +2% | +$21.4K |
|
|
SHOS
1920
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $1.36M | ﹤0.01% |
63,477
-136,107
| -68% | -$3M |
|
1921
California Water Service
CWT
$3.1B
| $1.36M | ﹤0.01% |
56,300
-178,000
| -76% | -$4.01M |
|
1922
Global Indemnity Group
GBLI
$402M
| $1.36M | ﹤0.01% |
52,350
-8,500
| -14% | -$224K |
|
1923
Heritage Financial
HFWA
$1.22B
| $1.36M | ﹤0.01% |
84,594
+57,096
| +208% | +$928K |
|
1924
Mannatech
MTEX
$9.3M
| $1.36M | ﹤0.01% |
111,960
+1,900
| +2% | +$28.6K |
|
|
PRFT
1925
DELISTED
Perficient Inc
PRFT
| $1.36M | ﹤0.01% |
69,793
-44,286
| -39% | -$802K |
|
Similar funds
Renaissance Technologies's Q2 2014 Portfolio in Review
As of Q2 2014, Renaissance Technologies held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Renaissance Technologies added most to Pfizer in Q2 2014, an estimated $276M increase.
- Renaissance Technologies's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Renaissance Technologies fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Renaissance Technologies's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Renaissance Technologies opened 450 new positions and closed 492 in Q2 2014.
- Renaissance Technologies's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.